The World Hypertension Market 2005-2010

Abstract

The world hypertension market generated over $25 billion in 2004, with steady growth from the previous year. In this report, visiongain forecasts that revenues in the world hypertension market will grow to nearly $30 billion per year by 2010.

This market report examines the prospects of the world hypertension market from 2005-2010. This market is one of the largest and most important in the pharmaceutical industry. Furthermore, the treatment of hypertension is a central part of cardiovascular healthcare itself at the forefront of public health.

This report examines the hypertension market critically through a comprehensive review of available information, including that from commercial databases, pipeline reports, academic research and consultation with international experts. Visiongain provides forecasting, SWOT analysis and the assessment of unmet needs to provide comprehensive financial forecasts, in-depth analyses and informed opinion.

In particular, this report concentrates on the following important issues:

• The current state of the world market for drugs to treat hypertension
• Drivers and opportunities in the hypertension market
• Restraints and threats in the hypertension market
• How the overall hypertension market is likely to grow between 2005-2010
• Prospects for the current market leading drugs between 2005-2010
• The potential for generics manufacturers to penetrate this market further
• A breakdown of the world hypertension market into the principal geographical markets, with estimates of potential treatment populations and forecasted revenues in 2010
• A discussion of unmet needs in the world hypertension market, with contributed opinions from experts
• Detailed information on pipeline products and line extensions in this market

Why You Should Buy This Report

• To receive a comprehensive analysis of the prospects of the world hypertension market from 2004-2010
• To find out predicted revenues, growth rates and market shares for all the leading antihypertensive drugs from 2005-2010
• To determine the forces that influence the hypertension market, especially:
  • Competitive characteristics
  • Drivers and restraints
  • Strengths, weaknesses, opportunities and threats
  • Unmet needs according to world experts, with gaps in the market exposed
• To find out the prospects for antihypertensive drugs in the leading geographical markets:
  • Potential treatment populations
  • Potential 2010 revenues in the leading 7 markets
  • Potential for growth of the hypertension market in other regions
• To find out about pipeline developments for treating hypertension, as well as recent product launches